Loading page…
Healthcare
Teva Pharmaceutical Industries (Healthcare) attains an AlphaScore of 69/100 as of 2026-10-11, securing a grade of B and a Watch signal. The metrics show a gross margin of 51.79% and a low debt-to-equity ratio of 0.23. A primary strength is the favorable forward PE ratio of 13.29 compared to its trailing PE of 68.5. A notable risk is the modest net margin of 8.17%. Evidence is restricted to the supplied data.
Written 11/10/2026, 00:32:17 UTC · Snapshot 11/10/2026